Feedback

X
Personalized and Precision Medicine 2022

Personalized and Precision Medicine 2022

0 Ungluers have Faved this Work
This reprint, guest edited by Anne-Marie Caminade, gives an impressionist overview of the current state of the art about “Personalized and Precision Medicine”. Twenty contributions illustrate the diversity of the topic, including new approaches about cancers, neurodegenerative diseases, infectious diseases, lungs obstruction, skeletal diseases, intestinal microbiomes, new tools such as ultra-high-frequency ultrasound or non-oncological radiotherapy, and a new class of drugs (dendrimers). This reprint is an illustration of the present and future impact of Personalized and Precision Medicine on all the therapeutic domains.

This book is included in DOAB.

Why read this book? Have your say.

You must be logged in to comment.

Rights Information

Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.

Downloads

This work has been downloaded 25 times via unglue.it ebook links.
  1. 25 - pdf (CC BY) at Unglue.it.

Keywords

  • 3D printing
  • Alzheimer’s disease
  • autoimmune
  • autoimmune disease
  • Autonomic Nervous System
  • AZA
  • bacteremia
  • black elderberry
  • bone-anchored maxillary protraction
  • Cancer
  • cancer treatment
  • carbapenem-resistant Enterobacteriaceae
  • carbapenemase
  • Cerebral palsy
  • chronic obstructive pulmonary disease
  • clinical decision rules
  • clinical trials
  • combination therapy
  • comorbidities
  • Complications
  • COVID-19
  • COVID-associated mucormycosis
  • cumulative incidence of hepatotoxicity
  • cystectomy
  • Dendrimers
  • diabetes
  • differential interactome
  • disease burden
  • DNA Methylation
  • druggability
  • Electromyography
  • Empathy
  • epigenomics
  • fast track rehabilitation
  • genetic counselling
  • Genetic Testing
  • growth modification
  • hallmarks of cancer
  • Heart rate variability
  • hepatotoxicity
  • Humans
  • Huntington’s disease
  • imaging
  • immune checkpoint blockade
  • Immunosuppression
  • inpatient rehabilitation
  • interorganizational transaction
  • kinematic
  • kinetic
  • Klebsiella pneumoniae
  • logopenic variant primary progressive aphasia
  • Low back pain
  • low-molecular-weight heparin
  • lumbar belt
  • medicine
  • microbiota
  • Mortality
  • mucormycosis
  • Multiple Sclerosis
  • muscle
  • muscle spasticity
  • musculoskeletal
  • n/a
  • neoadjuvant therapy
  • non-malignant disorders
  • non-oncological radiotherapy
  • obstructive sleep apnea
  • overlap syndrome
  • patient reported outcome measures
  • PD-(L)1 inhibitors
  • personalized medicine
  • personalized treatments
  • Pharmacogenomics
  • phases 1, 2, and 3
  • polyamidoamine
  • polylysine
  • Polyphenols
  • postoperative rehabilitation
  • Prebiotic
  • preemptive genotyping
  • primary cell culture
  • prognosis
  • psychosocial effects
  • Radiotherapy
  • regulatory non-coding RNAs
  • Risk factors
  • satellite cells
  • sit-to-stand
  • skeletal
  • skeletal class III malocclusion
  • skeletal muscle
  • Sleep
  • Steroids
  • system biomarkers
  • Thromboembolism
  • Total knee arthroplasty
  • TPMI
  • TPMT genotype
  • TPMT intermediate metabolizers
  • TPMT poor metabolizers
  • ultra-high frequency
  • ultrasound
  • underserved region
  • urinary bladder neoplasms
  • Vitamin D

Links

DOI: 10.3390/books978-3-0365-7044-0

Editions

edition cover

Share

Copy/paste this into your site: